Abstract

Background The main objective of this meta-analysis was to investigate whether remote ischemic preconditioning (RIPC) reduces cardiac and renal events in patients undergoing elective cardiovascular interventions. Methods and Results We systematically searched articles published from 2006 to 2016 in PubMed, EMBASE, Web of Science, Cochrane Library, and Google Scholar. Odds ratios (ORs) with 95% confidence intervals (CIs) were used as the effect index for dichotomous variables. The standardized mean differences (SMDs) with 95% CIs were calculated as the pooled continuous effect. Sixteen RCTs of 2435 patients undergoing elective PCI were selected. Compared with control group, RIPC could significantly reduce the incidence of perioperative myocardial infarction (OR = 0.64; 95% CI: 0.48–0.86; P = 0.003) and acute kidney injury (OR = 0.56; 95% CI: 0.322–0.99; P = 0.049). Metaregression analysis showed that the reduction of PMI by RIPC was enhanced for CAD patients with multivessel disease (coef.: −0.05 [−0.09; −0.01], P = 0.022). There were no differences in the changes of cTnI (P = 0.934) and CRP (P = 0.075) in two groups. Conclusion Our meta-analysis of RCTs demonstrated that RIPC can provide cardiac and renal protection for patients undergoing elective PCI, while no beneficial effect on reducing the levels of cTnI and CRP after PCI was reported.

Highlights

  • Percutaneous coronary intervention (PCI) is one of the most important treatments for coronary artery disease

  • In the present meta-analysis of 16 randomized trials that enrolled 2,435 adult patients who underwent elective PCI, we evaluated whether remote ischemic preconditioning can offer a protective effect by reducing cardiac and renal events

  • The results showed that remote ischemic preconditioning (RIPC) was unable to reduce the concentration of cTnI at 12 h and 24 h after elective PCI, and there was a high degree of heterogeneity in the included studies (I2 = 93.2%)

Read more

Summary

Introduction

Percutaneous coronary intervention (PCI) is one of the most important treatments for coronary artery disease. Many studies have shown that elevated levels of cTnI after PCI are associated with a poor prognosis in patients with coronary artery disease [3,4,5,6,7]. Many clinical studies have confirmed that RIPC provides effective myocardial protection in patients undergoing PCI, and RIPC is an important method to prevent MIRI. The main objective of this meta-analysis was to investigate whether remote ischemic preconditioning (RIPC) reduces cardiac and renal events in patients undergoing elective cardiovascular interventions. Our meta-analysis of RCTs demonstrated that RIPC can provide cardiac and renal protection for patients undergoing elective PCI, while no beneficial effect on reducing the levels of cTnI and CRP after PCI was reported

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call